ID | 1219 |
Name of the vaccine | ACAM2010 |
Microbe | Bacteria |
Disease name | E.coli Infections |
Name of bacteria | Escherichia coli |
Type of vaccine | Live attenuated |
Nucleic acid content | Circular duplex DNA |
Age | 18 to 49 years |
Description of the vaccine | CFA/I expressing ETEC vaccine |
Name of the manufacturer | NA |
Name of the manufacturing country | NA |
Year of manufacture | NA |
Clinical Phase status | Clinical - Phase 1 |
Bacterial strain | Gram-negative, rod-shaped bacteria. |
Efficacy | NA |
Vaccine formulation | NA |
Dosage | Two doses. |
Mechanism of action | ASC, ALS, serology, only DFA-I-specific IgA in serum and WGLF. |
Route of administration | Oral |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | NA |
Repurposing | NA |
Side effects of vaccine | Non-serious adverse events. |
Post vaccination | NA |
Dose type | Combination (2 doses) |
Interspecies transfer | NA |
PubMed identifier | 17566016 |
Clinical trial number | NA |
Reference | http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=116&keywords= |
Other name | NA |
Additional Links | NA
|